Original text
Rate this translation
Your feedback will be used to help improve Google Translate
Home
Alembic Pharmaceuticals Limited
Press Release Apr 20 2022
Business
Apr 20 2022
4 min read

Press Release Apr 20 2022

Alembic Pharmaceuticals Limited has informed the Exchange about press release dated 20-Apr-2022 titled Alembic Pharmaceuticals Limited receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg.

View Attachment